In This Article:
CFO and Head of Strategy of Penumbra Inc (30-Year Financial, Insider Trades) Sridhar Kosaraju (insider trades) sold 5,000 shares of PEN on 08/01/2019 at an average price of $169.36 a share. The total sale was $846,800.
Penumbra Inc designs, develops, manufactures and markets medical devices. The products of the company address ischemic stroke, hemorrhagic stroke and vascular conditions that can be treated through thrombectomy and embolization procedures. Penumbra Inc has a market cap of $5.63 billion; its shares were traded at around $162.12 with a P/E ratio of 540.38 and P/S ratio of 12.76. GuruFocus has detected 2 severe warning signs with Penumbra Inc. .
CEO Recent Trades:
-
Chairman, CEO and President Adam Elsesser sold 8,000 shares of PEN stock on 07/11/2019 at the average price of $171.84. The price of the stock has decreased by 5.66% since.
CFO Recent Trades:
-
CFO and Head of Strategy Sridhar Kosaraju sold 5,000 shares of PEN stock on 08/01/2019 at the average price of $169.36. The price of the stock has decreased by 4.27% since.
Directors and Officers Recent Trades:
-
Director Thomas Wilder sold 237 shares of PEN stock on 07/15/2019 at the average price of $169.92. The price of the stock has decreased by 4.59% since.
For the complete insider trading history of PEN, click here
.This article first appeared on GuruFocus.